Advanced Filters
noise
Found 64,920 clinical trials

Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 Diabetes

Despite recent medical and technological advances, optimal glycemic control (time in range; TIR) and prevention of hypoglycemia remain significant challenges for people living with type 1 diabetes (T1DM). Automated insulin delivery systems (AIDs) combine an insulin pump coupled via an algorithm with a continuous glucose monitor (CGM), allowing constant adjustment …

18 years of age All Phase N/A
X Xubin Zheng, MPH, PhD

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

The incidence and prevalence of nontuberculous mycobacteria (NTM) infections have gradually increased over the years worldwide (1-3). In China, Mycobacterium avium complex (MAC) was the most prevalent NTM specie (4), while challenged by long treatment duration, frequent drug-induced adverse events, lack of treatment alternatives, poor treatment outcome and high recurrence …

18 years of age All Phase N/A
D Dr Aïssata BARRY, DR

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.

- 18 years of age All Phase N/A
H Harun Gençosmanoğlu, PT, MSc

Cognitive Exercise Therapy Approach Biopsychosocial Questionnaire (BETY-BQ) in Patient With Temporomandibular Disorders

The aim of this study is to investigate the validity, reliability, and responsiveness of the Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ) in individuals with temporomandibular disorder. The following are alternative hypotheses of the study: BETY-BQ has significant convergence with the Patient Health Questionnaire-9 measuring depression. BETY-BQ has significant convergence with …

18 - 64 years of age All Phase N/A
X Xiaomin Niu

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Immunotherapy has improved the prognosis of non-small cell lung cancer (NSCLC) patients, but about 80% of patients do not respond at all, which is called primary resistance. Absence of the PD-L1 expression is regarded as one of primary resistant reasons to immunotherapy, there are some other reasons which have been …

18 years of age All Phase N/A
E Eva M Montalvá, PhD

Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases

Multicentric prospective and observational study to assess the 5-year overall survival in a cohort of patients with unresectable liver-only colorectal metastases, well controlled by chemotherapy prior to liver transplantation.

18 - 65 years of age All Phase N/A
J Jose A. Roshardt, Dr.

Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint

In this study, the investigators seek to validate 3D model-based dGEMRIC (delayed gadolinium enhanced MRI of cartilage) values against histologic grading of cartilage quality, using osteochondral samples of the femoral head collected during hip replacement surgery.

18 years of age All Phase N/A
Å Åsa Waldum, PhD

Fetal Assessment of the Myocardium and Evaluation of the Neonate

FAME-n aims to improve perinatal care by introducing new approaches to fetal and neonatal heart assessment. Better identification of high-risk deliveries requiring intervention will reduce perinatal asphyxia-related illness and death. Neonatal hemodynamics may be improved by early detection of instability of the heart and circulation. Innovative use of technology enables …

years of age All Phase N/A
R Riemer Slart, Prof MD PhD

Quantitative-imaging in Cardiac Transthyretin Amyloidosis

Transthyretin amyloid cardiomyopathy (ATTR-CM), is a heart muscle disease that's stops the heart muscle working properly. With an ageing population, it is increasingly common but untreated, it has a poor prognosis. Several novel expensive treatments have become available, although we do not understand exactly how they work and why some …

40 years of age All Phase N/A
j jinsong Lu, MD

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

This is an ambispective, single-center study to evaluate the survival outcomes, adverse events and predictive biomarkers for CDK4/6 inhibitors in patients with hormone receptor-positive advanced breast cancer.

18 years of age All Phase N/A

Simplify language using AI